News & Updates

For patients who are struggling to lose weight after metabolic bariatric surgery, treatment with liraglutide boosts weight-loss outcomes and helps avoid conversion surgery, as shown in a randomized clinical trial.

The reduction in relative risk with intensive vs standard systolic blood pressure (SBP) treatment among individuals without baseline cardiovascular disease (CVD) is consistent across the risk strata using the PREVENT* equations, as shown in the SPRINT study.

Breastfeeding provides several benefits to mothers and their children, including reduced risks in sudden infant death syndrome and allergic rhinitis, as well as improved physical fitness, reports a study.

Toddlers born to mothers with psychological distress through 1 year postpartum are more likely to have neurodevelopmental delay, according to a study.

First-line treatment with sacituzumab govitecan, an antibody drug conjugate, significantly improved progression-free survival (PFS) compared with chemotherapy in patients with metastatic triple-negative breast cancer (TNBC), according to the ASCENT-03 trial presented at ESMO 2025. 

Among patients who sustained COVID-19 infection, the risk of postacute sequelae of SARS-CoV-2 (PASC) is high in the presence of a serious mental illness, according to a study.

Individuals who sustained an acute dengue virus infection are predisposed to cardiovascular events up to 30 days after infection, although the excess risk was modest, according to a study from Singapore.